Literature DB >> 2449556

Modified versus classical Blalock-Taussig shunts for congenital cyanotic heart diseases: a comparison of long-term results.

K Sakai1, K Goh, T Gohda, M Sakuma, O Matsunami, K Yasuda, T Tanabe, T Murakami.   

Abstract

Between March 1977 and December 1984, 103 Blalock-Taussig shunts were performed on 88 patients. Included in this study were 40 patients who underwent the modified BT shunt and 63 patients who underwent the classical BT shunt. 13 of the modified BT shunts (33 per cent) and 18 of the classical BT shunts (29 per cent) were performed during infancy and 10 of the modified BT shunts (25 per cent) were performed on patients under the age of 3 months. EPTFE grafts of varying sizes were used in the patients who underwent modified BT shunts--4 mm in 14 cases, 5 mm in 15 cases and 6 mm in 11 cases, respectively. The early mortality rate was 11 per cent (3 deaths) in the group who had modified BT shunts and 8 per cent (5 deaths) in the group who had classical BT shunts. Over a follow-up period of 6 years, 6 shunt failures were diagnosed in the modified BTS group by auscultation and/or angiographic study, and during a follow-up period of 8 years, 12 shunt failures were diagnosed in the classical BTS group. The patency rate 3 years after surgery was 88.8 per cent in the modified BTS group and 78.0 per cent in the classical BTS group. The patency rate 5 years after surgery was 88.8 per cent in the modified BTS group and 75 per cent in the classical BTS group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2449556     DOI: 10.1007/bf02470751

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  12 in total

1.  Microporous expanded polytetrafluoroethylene arterial prosthesis for construction of aortopulmonary shunts: experimental and clinical results.

Authors:  A B Gazzaniga; M P Elliott; D R Sperling; W R Dietrick; J T Eiseman; D M McRae; R H Bartlett
Journal:  Ann Thorac Surg       Date:  1976-04       Impact factor: 4.330

2.  Changes in muscle blood flow and development of the arm following the Blalock-Taussig anastomosis.

Authors:  J Skovránek; J Goetzová; M Samánek
Journal:  Cardiology       Date:  1976       Impact factor: 1.869

3.  Expanded polytetrafluoro-ethylene as a small artery substitute.

Authors:  C D Campbell; D Goldfarb; D D Detton; R Roe; K Goldsmith; E B Diethrich
Journal:  Trans Am Soc Artif Intern Organs       Date:  1974

4.  [Systemic-pulmonary artery shunts using expanded polytetrafluoroethylene (EPTFE) grafts].

Authors:  T Gohda; M Sakuma; O Matsunami; K Yasuda; K Sakai; T Tanabe; T Murakami
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1985-03

5.  Vascular consequences of subclavian artery transection for the treatment of congenital heart disease.

Authors:  F A Lodge; J J Lamberti; A H Goodman; S E Kirkpatrick; L George; J W Mathewson; J D Waldman
Journal:  J Thorac Cardiovasc Surg       Date:  1983-07       Impact factor: 5.209

6.  Results of two-stage surgical treatment of tetralogy of Fallot.

Authors:  E Arciniegas; Z Q Farooki; M Hakimi; E W Green
Journal:  J Thorac Cardiovasc Surg       Date:  1980-06       Impact factor: 5.209

7.  Classic shunting operations for congenital cyanotic heart defects.

Authors:  E Arciniegas; Z Q Farooki; M Hakimi; B L Perry; E W Green
Journal:  J Thorac Cardiovasc Surg       Date:  1982-07       Impact factor: 5.209

8.  Modified Blalock-Taussig shunt in newborn infants.

Authors:  M N Ilbawi; J Grieco; S Y DeLeon; F S Idriss; A J Muster; T E Berry; J Klich
Journal:  J Thorac Cardiovasc Surg       Date:  1984-11       Impact factor: 5.209

9.  Modified Blalock-Taussig shunt in infants and young children. Clinical and catheterization assessment.

Authors:  P P Karpawich; C P Bush; J R Antillon; J J Amato; M L Marbey; K C Agarwal
Journal:  J Thorac Cardiovasc Surg       Date:  1985-02       Impact factor: 5.209

10.  Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.

Authors:  M R de Leval; R McKay; M Jones; J Stark; F J Macartney
Journal:  J Thorac Cardiovasc Surg       Date:  1981-01       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.